Delivery Order SPE2DB22D3301-SPE2DB24FX9WN

Award Date 2/1/24
Potential Completion Date 2/2/24
Potential Value $7.3K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,563,824,205 units of the pharmaceutical product CARVEDILOL ER 10 MG CAPSULE 30S. The contract has a potential value of $1,633.64 and a completion date of March 4, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor providing a wide range of pharmaceutical products and medical...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $3,939.61 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of CARVEDILOL ER 80 MG CAPSULE 30S. This Firm Fixed Price contract has a completion date of May 23, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the primary vehicle for delivering a comprehensive range of pharmaceutical...
The Defense Logistics Agency (DLA) awarded a delivery order contract valued at $26,526.08 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 4564836181 - CARVEDILOL ER 40 MG CAPSULE 30S. This order falls under Amerisourcebergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a ceiling value of $999,999,999.00 and runs through December 31, 2025. The IDC enables DLA to efficiently procure a comprehensive range of pharmaceutical products...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of CARVEDILOL ER 40 MG CAPSULE 30S. The contract has a potential value of $12,688.79 and a completion date of March 5, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor and will deliver the pharmaceutical product to the DLA Troop Support Medical facilities supporting the Department...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of CARVEDILOL ER 40 MG CAPSULE 30S. The contract has a potential value of $5,929.73 and a completion date of February 7, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor for this delivery order. The company also holds an indefinite delivery contract (IDC) with a potential value of...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide CARVEDILOL ER 40 MG CAPSULE 30S. The contract has a potential value of $9,694.92 and a completion date of February 15, 2024. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which was issued under a larger indefinite delivery contract (IDC) with DLA with a potential value...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $9,596.30 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division to provide 4564743336 - CARVEDILOL ER 10 MG CAPSULE 30S. This order is part of Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide CARVEDILOL ER 10 MG CAPSULE 30S. The contract has a completion date of January 30, 2024 and a potential value of $2,118.62. No set-aside designation was used for this award. Amerisourcebergen Drug Corp is the prime contractor and this delivery order was issued under a larger indefinite delivery contract (IDC) valued at...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,592.68 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of CARVEDILOL ER 20 MG CAPSULE 30S, a pharmaceutical product, to be completed by February 7, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award, which is not associated with any set-aside...
The U.S. Defense Logistics Agency (DLA) awarded a $3,637.82 Firm Fixed Price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of 4565874638 CARVEDILOL ER 20 MG CAPSULE 30S, with a completion date of September 20, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which enables the agency to...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB24FX9WN
    Delivery Order

The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract worth $7,251.35 for the provision of 4563516363 ! CARVEDILOL ER 40 MG CAPSULE 30S. This contract does not have a set-aside designation and is scheduled for completion by February 2, 2024. Amerisourcebergen Drug Corp serves as the prime contractor, delivering the pharmaceutical product to support military treatment programs and facilities. This award is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00, which was awarded solely to Amerisourcebergen Drug Corp by DLA and serves as the primary contract vehicle for the company to provide a comprehensive range of medications and healthcare materials to the Department of Defense worldwide.

Generated 5/2/24, 9:17 AM